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doi:10.1016/j.kjms.2011.10.006Abstract In 2005, a national pilot harm reduction program (PHRP), which mainly included
a methadone maintenance treatment program (MMTP) and a needle/syringe exchange program
(NSP), was implemented in Taiwan. We conducted this study to evaluate the effectiveness of
harm reduction measures on HIV control among injecting drug users (IDUs) between PHRP and
nonPHRP. The data on HIV, collected from incumbent Taiwanese authorities, were analyzed for
their associations, risk and protective factors with PHRP measures. While the monthly HIV inci-
dences did not show significant differences before and after PHRP in the four areas with PHRP
(Taipei City, Taipei County, Taoyuan County and Tainan County), a significant increase in the
HIV incidence was found in the 21 areas without PHRP. Hence, the implementation of the PHRP
did result in a significant difference in the monthly HIV incidence between areas with and
without the PHRP. Mandatory HIV testing was significantly associated with the HIV incidence
according to the generalized estimation equations (GEE) model. With adjustments of time
period and area with PHRP, and urban area, protective factors associated with HIV incidence
were: educational materials, condoms, dilution water, and alcohol sponges/swabs. MMTP
contributed to a higher HIV incidence, probably due to the concurrent HIV testing upon admis-
sion. Since HIV testing was not required in the NSP, the HIV testing-dependent MMTP mayarmacy, Kaohsiung Medical University, No.100 Shih-Chuan 1st Road, Kaohsiung City 807, Taiwan.
w (J.-H. Li).
vier Taiwan LLC. All rights reserved.
80 H.-Y. Lee et al.explain the association of the PHRP intervention and an increased HIV incidence. In summary,
HIV testing and education were essential for effective HIV control upon implementing
the PHRP.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Introduction
It has been reported that a methadone maintenance
treatment program (MMTP) and needle/syringe exchange
program (NSP), two major pillars of harm reduction, are
effective measures against HIV/AIDS among injecting drug
users (IDUs) [1e4]. First identified in 1981, the HIV/AIDS
epidemic lingers on into the 21st century. Such public health
approaches have proved cost-effective to curb the spread
of HIV in comparison with costly antiretroviral therapies
and unavailable vaccinations [5,6]. However, doubts have
also been raised regarding the effectiveness of these harm
reduction measures for HIV/AIDS. For example, it has been
argued that the stage of HIV epidemic and the level of HIV
seropositivity among IDUs may confound the effectiveness
of a NSP in the reduction of the incidence of HIV/AIDS [7].
In addition, the performance of a randomized controlled
trial to test the effectiveness of NSPs in reducing the inci-
dence of HIV has been considered impossible for reasons of
ethical and logistical impediment [8].
In Taiwan, the incidence of HIV/AIDS surged in 2004
after a dormancy of two decades [9]. Prior to 2003, the HIV
incidence was mostly due to men having sex with men
(MSM) [10]. However, the percentage of IDUs among all
addiction treatment admissions increased from 34.7% in
2000 to 63.9% in 2004, and the percentage of IDUs sharing
needles increased from 4.0% in 2000 to 15% in 2004 [11].
Further investigation indicated that the major risk factors
for Taiwanese IDUs were needle-sharing, followed by the
sharing of dilution water [12]. A national pilot harm
reduction program (PHRP), with measures including mainly
a needle/syringe exchange program (NSP), a methadone
maintenance treatment program (MMTP) and HIV education
and counseling, was initiated in four of Taiwan’s 25
administrative areas in August 2005. One year after the
PHRP, the Taiwan Centers for Disease Control (TCDC) re-
ported a dramatic 10% decrease in all new HIV seropositive
cases, and a nationwide harm reduction program was
subsequently implemented [13].
The report of the TCDC on the effectiveness of the PHRP
in Taiwan supported previous studies [13,14]. However,
after scrutinizing the data of the PHRP, we found that some
other factors may also be involved in the claimed effec-
tiveness. For example, mandatory HIV testing, which took
effect in April 2004 in drug users who violated the Narcotics
Control Act, could have expanded the base of new HIV
cases and explained, at least in part, the surge in the
incidence of HIV. In addition, so far the effects of harm
reduction measures on HIV control have not been evaluated
owing to the lack of an experimental/control design.
Hence, the implementation of the PHRP in four adminis-
trative areas in Taiwan has provided us with a rare
evidence-based opportunity to compare the harm reduction
effectiveness in those areas with the PHRP to that in theother 21 administrative areas without a PHRP. For future
HIV preventive purposes, it is also imperative to evaluate
the factors of the PHRP that contribute to the reduction
in the incidence of HIV. We therefore attempted to eval-
uate the effectiveness of the measures of harm reduction
and their associated factors on the incidence of HIV/AIDS.Materials and methods
Taiwan, an island country with a population of 22,770,383
in 2005, is composed of 25 administrative areas (7 cities and
18 counties). A city is defined as an urbanized area with
a population of more than 300,000 residents. A county is
a suburban and rural area with satellite cities or town-
ship(s) where the population is lower than that of a city.
Four administrative areas, including one city (Taipei)
and three counties (Taipei, Taoyuan and Tainan), volun-
tarily participated in the PHRP. The PHRP was approved by
the Executive Yuan (Cabinet), Taiwan, R.O.C., and was
launched from August 2005 to June 2006. The other 21
areas without a PHRP therefore served as control groups.
This observational study was designed to compare the
change over time in the incidence of HIV in these areas of
Taiwan before or after the implementation of PHRP in the
areas with and without a PHRP from 2004 to 2006. The HIV/
AIDS data were obtained from the national HIV/AIDS
registry of the TCDC [15,16], in which physicians are
requested by law to report identified cases of HIV infection
and AIDS within 24 h of diagnosis. Patients’ information,
including name, identification card number, gender, home
address, date of birth, date of diagnosis, occupation and
risk factors are recorded on a case report form.
In the process of PHRP implementation, the NSP and
MMTP were developed simultaneously. The NSP was estab-
lished to distribute free needles and syringes, but one-for-
one syringe exchange was not strictly demanded. In the NSP
sites, free condoms, sterile paraphernalia including dilution
water, alcohol sponges/swabs for cleaning injection sites
and educational materials regarding the prevention of
blood or sexually transmitted disease (STD) were also
supplied. The returned contaminated needles and syringes
were collected and the syringe return rate was determined
as the returned contaminated needles and syringes divided
by the distributed clean needles and syringes. The HIV
incidence was determined as the number of new HIV cases
divided by the population of the specified area per month
per 1,000,000 persons.
According to the regulations of the TCDC, HIV-infected
IDUs can receive methadone treatment free of charge,
while HIV seronegative IDUs are charged ca. US$1600 per
year for the same treatment [13]. The quantities of mate-
rials delivered to IDUs in the NSP and the number of IDUs
who participated in the MMTP were also recorded. All data
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TCDC [15,16].
The monthly HIV incidences of the administrative areas
(city/counties) were used as observations in the analysis
database. Basic information regarding the city/county
characteristics and the PHRP policy was also obtained as
analysis covariates. To examine the impact of the PHRP on
the HIV trend in Taiwan, generalized estimation equations
(GEE) were adopted with Poisson as the probability distri-
bution function and the first-order autoregressive as the
correlation structure [17e19]. HIV incidences from August
2004 to June 2005 (before the PHRP) and August 2005 to
June 2006 (during the PHRP) were included in the analysis.
As the populations of the cities/counties vary, the weights
according to the size of the cities/counties were incorpo-
rated into the statistical analysis. Analyses of the HIV inci-
dences were performed to ensure that the HIV situations of
all areas with or without the PHRP were comparable.
To investigate the potential effects (factors including
mandatory screening, PHRP intervention, PHRP area, urban
area and numbers of distributed clean syringes, returned
syringes, patients on methadone, and distribution of
condoms, dilution water, alcohol sponges/swabs and
educational materials) on the outcome of HIV incidence, the
univariate GEE model was first used to compute the indi-
vidual odds ratio for each effect. The effects of the numbers
of distributed clean syringes, returned syringes and patients
on methadone, and the distribution of condoms, dilution
water, alcohol sponges/swabs and educational materials
on HIV incidence were further investigated by separate
multivariate GEE models with the additional covariates of
mandatory screening, PHRP intervention, PHRP area, inter-
action effects of PHRP intervention and areas and urban
area. The PROC GENMOD of SAS software was used to
implement the analysis of the GEE models.
In these analyses, all p values were two-sided, with the
statistical significance set at p < 0.05. All statistical anal-
yses were performed using SAS software version 9.1 (SAS
Institute, Cary, NC, USA).Results
The PHRP was officially initiated in four administrative areas
of Taiwan in August 2005 until June 2006. Subsequently,Table 1 Basic PHRP measures implemented in four administrat
PHRP Measures Taipei County Taina
NSP
clean needles and syringes (set) 41,609 (26%) 111,1
condoms (dozen/box) 1408 (20%) 4422
dilution water (amp) 2083 (18%) 8237
alcohol sponges/swabs (pack) 2197 (8%) 22,15
educational materials (package) 245 (8%) 2216
returned syringes (set) 10,247 (46%) 11,69
return rate 24.63% 10.52
MMTP
patients 34 (9%) 79 (2
MMTP Z methadone maintenance treatment program; NSP Z needlea nationwide harm reduction program was implemented in
all 25 administrative areas of Taiwan in July 2006. Of the
four areas in which the PHRP was launched, the NSP was not
executed in Taoyuan County during this PHRP period. Among
the other three administrative areas, i.e., Taipei County,
Taipei City and Tainan County, educational materials for the
NSP were mostly distributed in Tainan County (Table 1). The
syringe return rates were 24.63%, 12.57% and 10.52% in
Taipei County, Taipei City and Tainan County, respectively.
In addition, 385 individuals were admitted to six hospitals
for an outpatient MMTP (Table 1). Among the 385 patients,
a majority of 249 (65%) were treated in Taoyuan County.
The GEE analyses for the monthly HIV incidence trend
are shown in Table 2, and no significant differences were
observed between before and after the PHRP in the four
areas in which the PHRP was initiated (p Z 0.89). For the
areas without a PHRP, the mean HIV incidence significantly
increased by 3.69 per 1,000,000 persons. Moreover, there
was also no significant difference in the monthly HIV inci-
dence between areas with a PHRP (n Z 4) and those
without a PHRP (nZ 21) either before the PHRP (pZ 0.38)
or after the PHRP (p Z 0.57). A significant interaction
effect (p Z 0.02) was found between areas with/without
a PHRP and the time period with/without a PHRP. Hence,
the implementation of the PHRP did result in a significant
difference in the monthly HIV incidence between the areas
with and without the PHRP.
The GEE analyses of the PHRP-related factors are pre-
sented in Table 3. According to the univariate analyses, the
factors associated significantly with the HIV incidence
included mandatory HIV testing (odds ratio (OR) 2.55, 95%
CI: 1.97e3.30); PHRP intervention (OR 1.53, 95% CI:
1.30e1.79); and methadone treatment (OR 7.45, 95% CI:
3.93e14.13). In other words, mandatory HIV testing since
April 2004 due to violation of the Narcotics Control Act (OR
2.55) and the PHRP intervention period (OR 1.53) resulted
in a significantly higher HIV incidence as compared to a lack
of mandatory HIV testing or a PHRP intervention period.
With adjustment for mandatory screening, time period
and administrative area with PHRP intervention, and the
urban area, the protective factors associated with HIV
incidence in our multivariate GEE analysis were the provi-
sion of condoms (AOR 0.86, 95% CI: 0.83e0.89), dilution
water (AOR 0.93, 95% CI: 0.91e0.96), alcohol sponges/
swabs (AOR 0.97, 95% CI: 0.96e0.98), and educationalive areas of Taiwan from August 2005 to June 2006.
n County Taipei City Taoyuan County Total
65 (71%) 4358 (3%) d 157,132
(63%) 1217 (17%) d 7047
(72%) 1189 (10%) d 11,509
0 (79%) 3854 (14%) d 28,201
(72%) 638 (21%) d 3099
7 (52%) 548 (2%) d 22,492
% 12.57% d 47.72%
1%) 23 (6%) 249 (65%) 385
/syringe exchange program.
Table 2 Comparison of HIV incidence among administrative areas before or after and with or without PHRP.
Mean incidence
(SD) in Time 1
Mean incidence
( SD) in Time 2
Mean incidence
difference (95% CI)
Time 2 vs. Time 1
p value
Areas with PHRP (n Z 4) 11.55  1.84 11.44  2.17 0.11 (2.60, 2.39) 0.89
Areas without PHRP (n Z 21) 9.25  1.72 12.94  2.07 3.69 (1.74, 5.64) <0.0001
Mean incidence difference (95% CI) 2.29 (0.32, 4.26) 1.50 (3.86, 0.86) 0.35 (0.64, 0.07)*
PHRP vs. non-PHRP, p value 0.38 0.57 0.02
The HIV incidence was determined as the number of new HIV cases divided by the population of the specified area per month per
1,000,000 persons. The unit of HIV incidence is defined as persons per 1,000,000 population.
Time 1 Z 11-month period before PHRP from August 2004 to June 2005.
Time 2 Z 11-month period during PHRP from August 2005 to June 2006.
A p value was based on the likelihood ratio test derived from the GEE model with Poisson as the underlying distribution, and the
multivariate model was adjusted by PHRP intervention period, PHRP area, and the interacting effect of these two factors. HIV incidence
was adjusted by the weight variable based on the population of each area.
P values were two-sided, with the statistical significance set at p < 0.05.
* This mean incidence difference was also estimated based on the likelihood ratio test derived from the GEE model with Poisson as the
underlying distribution, and the multivariate model was adjusted by PHRP intervention period, PHRP area and the interacting effect of
these two factors. HIV incidence was adjusted by the weight variable based on the population of each area.
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these associated factors, the distribution of educational
materials (AOR 0.73) had a greater protective effect than
the provision of clean syringes (AOR 0.99) and returnedTable 3 Analysis of factors associated with HIV incidence using
Univariate analysis
OR (95% CI)
Mandatory HIV testing
yes vs. no 2.55 (1.97, 3.30)
Time period with PHRP
yes vs. no 1.53 (1.30, 1.79)
Administrative area with PHRP
yes vs. no 1.14 (0.73, 1.78)
Urban Area
yes vs. no 1.03 (0.56, 1.87)
Clean syringes
per 1000 units 1.00 (1.00, 1.01)
Returned syringes
per 1000 units 1.01 (0.99, 1.04)
Methadone
per 1000 persons 7.45 (3.93, 14.13)
Condoms
per 1000 units 1.02 (0.91, 1.15)
Dilution water
per 1000 amps 1.01 (0.94, 1.07)
Alcohol sponges/swabs
per 1000 units 1.00 (0.98, 1.01)
Educational materials
per 1000 units 0.98 (0.84, 1.15)
The monthly record of each city was considered as one observation i
AORZ adjusted odds ratio for mandatory screening; CIZ confidence
P values were two-sided, with the statistical significance set at p < 0syringes (AOR 0.98). Thus, the distribution of educational
materials to IDUs appeared to have a better effect than the
provision of clean syringes in the control of HIV incidence.
Compared with other factors, methadone treatmentthe GEE models (nZ 25 administrative areas, monthsZ 30).
Multivariate analysis
p value AOR (95% CI) p value
<0.0001
<0.0001
0.56
0.93
0.69 0.99 (0.99, 1.00) 0.08
0.22 0.98 (0.96, 1.02) 0.56
<0.0001 2.99 (1.28, 6.97) 0.01
0.72 0.86 (0.83, 0.89) <0.0001
0.85 0.93 (0.91, 0.96) <0.0001
0.65 0.97 (0.96, 0.98) <0.0001
0.79 0.73 (0.63, 0.85) <0.0001
n this analysis model.
interval; ORZ odds ratio; PHRPZ intervention and urban area.
.05.
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95% CI: 1.28e6.97).Discussion
Harm reduction has been reported to be effective against
HIV/AIDS among IDUs. However, the effectiveness of harm
reduction remains controversial, not only because of its
obscure definition and concept, but also its entanglement
with drug abuse-related law enforcement/crime and lack
of control/experimental-based evidence [1e4,20]. Hence,
at the advent of the HIV epidemic, an evidence-based
response is desperately needed [21]. The implementation
of the PHRP in Taiwan provided such an opportunity to
evaluate the effectiveness of harm reduction on the control
of HIV.
As shown in Table 2, while the monthly HIV incidences
did not differ significantly before and after the imple-
mentation of the PHRP in the four areas with the PHRP
(Taipei City, Taipei County, Taoyuan County and Tainan
County), a significant increase in the HIV incidence was
found in the 21 areas without the PHRP. Hence, the
implementation of the PHRP did result in a significant
difference in the monthly HIV incidence between areas
with and without the PHRP.
Although a dramatic 10% decrease in all new HIV cases
was observed within a year of the initiation of the PHRP, at
least two other important national policies may have
affected the HIV/AIDS incidence before or during the PHRP
[8,13]. As summarized in Fig. 1, two HIV screening tests
were performed nationwide in illicit drug use suspects and
pregnant women in addition to the PHRP. Such thorough HIVFigure 1. Dates of important national policies on HIV
prevention and numbers of HIV-infected persons in three major
high-risk groups reported to the Taiwan Centers for Disease
Control from April 2004 through December 2006. There were at
least three important policies implemented before and during
the PHRP period. “1” denotes a mandatory HIV screening test,
which took effect in April 2004 in drug users who violated the
Narcotics Control Act. “2” represents a national program of HIV
screening initiated in pregnant women to prevent mother-to-
child transmission in January 2005. “3” represents the start
time of the MMTP, in which only 385 patients participated. In
July 2006, the harm reduction policy was fully implemented in
all administrative areas of Taiwan.testing may have expanded the basis of HIV incidence and
explained, at least in part, the surge in HIV incidence in
2005 and subsequent drastic decline in 2006. The effect of
HIV testing on HIV risk behaviors and incidence among IDUs
is well-documented [22e24]. As shown in Table 3, the
significant association of mandatory testing with HIV inci-
dence in the GEE analyses supports our inference that the
HIV testing implemented before the PHRP in IDUs did affect
the HIV incidence.
Given the low MMTP coverage rate (only 385 patients
were admitted for treatment among an estimated
60,000e100,000 IDUs in Taiwan, Table 1) and late stage
intervention (Fig. 1) [25], it seemed puzzling that the MMTP
was significantly associated with a higher HIV incidence risk
(OR 7.45, 95% CI: 3.93e14.13, Table 3). Such an association
persisted even after adjustment for mandatory testing,
time period and administrative area with PHRP interven-
tion, and the urban area (AOR 2.99, 95% CI: 1.28e6.97).
This association could be explained by the TCDC policy that
upon admission all MMTP patients were mandated to take
a HIV test, which could further broaden the basis of HIV
incidence [13]. Furthermore, the complimentary MMTP
treatment for HIV-seropositive IDUs may also encourage
these patients to participate in the MMTP. In contrast to the
MMTP, the implementation of the NSP (clean syringes and
returned syringes), for which HIV testing was not required,
did not significantly affect the HIV incidence (Table 3). As
the MMTP and the NSP were the two major measures in
Taiwan’s PHRP, the MMTP may be an important contributing
factor that was associated with PHRP and HIV incidence
(Table 3).
Using HIV incidence as the unit of analysis, and
controlling for other factors associated with HIV public
health policies, the distribution of HIV/AIDS educational
materials to the IDU population was the most protective
factor against HIV transmission among other factors asso-
ciated with the NSP. In other words, HIV education and
counseling assists IDUs to recognize HIV risk factors and
change their behavior related to injecting drugs [26]. Our
findings are in agreement with those of previous studies
that indicated that appropriate education and counseling
should be implemented simultaneously with the introduc-
tion of a NSP [7,22,26e29].
Our study showed that neither the distribution of clean
syringes nor the quantity of returned syringes was associ-
ated with HIV incidence. In Taiwan, IDUs were required to
return used syringes when they exchanged them for new
syringes in the NSP. Many studies have examined the rela-
tionship between syringe sharing and HIV incidence and
NSPs with different syringe dispensation policies, such as
the “one-for-one”, the “one-for-one-plus”, the “starter
pack” and the “distribution” syringe exchange programs
(SEPs) [30e33]. The “one-for-one” SEP gives clients the
same number of sterile syringes as were turned in by the
clients [33]. The “one-for-one-plus” SEP gives clients a few
more syringes than were turned in by the clients [33]. The
“starter pack” SEP gives clients a few syringes and they are
not required to turn in any used syringes [33]. The “distri-
bution” SEP gives clients the number of syringes that they
request, no matter how many syringes the clients turned in
[33]. Bluthenthal et al. and Kral et al. reported that less
restrictive dispensation polices, such as the “distribution”
84 H.-Y. Lee et al.SEP, have more clients and a lower proportion of reuse of
syringes and sharing syringes [32,33]. In Taiwan, the syringe
dispensation policy was similar to the “one-for-one-plus”
SEP; thus, this restrictive dispensation policy, which may
result in a lower exchange rate, may also cause negative
results for HIV incidence in Taiwan.
We also demonstrated that the distribution of more
condoms, dilution water, and alcohol/swabs was associated
negatively with HIV incidence. A previous study reported
that HIV seropositive IDUs were more likely to share dilution
water (87.5%) and containers (78.2%) in Taiwan [25]. From
the results of this study, we suggest that the distribution of
more dilution water to avoid IDUs sharing dilution water is
one of the protective factors against HIV spread. Moreover,
Huo et al. demonstrated that compared to Needle Exchange
Program (NEP) nonusers, NEP users had a 49% higher odds of
using condoms with their sexual partners, suggesting that
NEP participation may help to reduce the risk of sexual
transmission of HIV [34]. The ChinaeVietnam Cross Border
NEP distributed condoms and sterile syringes, and proved
that HIV prevalence and incidence fell by half after the
24-month survey [35]. Bleach and alcohol are commonly
utilized by IDUs to clean used syringes in other countries
[36,37]. In addition, Abdala et al. and Flynn et al. found that
bleach and rubbing alcohol to rinse syringes could signifi-
cantly decrease the rate of recovering infectious HIV-1
[38,39]. Therefore, distribution of more condoms and
alcohol/swabs are important protective factors in reducing
the incidence of HIV and may also remind IDUs of the
importance of safe sex and good sanitation.
It has been argued that at least two factors may
confound the effectiveness of NSPs in the reduction of HIV/
AIDS incidence, i.e., the stage of HIV epidemic may vary in
areas with and without a NSP and the level of HIV sero-
positivity among IDUs may not be recognized [7]. Hence, we
performed tests to ensure that the HIV situations of all the
areas with or without and before and after the PHRP were
comparable. However, there were a couple of limitations in
this study. First, during the implementation of the PHRP,
IDUs may have had the chance to participate in the NSP and
the MMTP simultaneously, but we did not know whether the
IDUs attended both the NSP and MMTP. If IDUs participated
in both the NSP and the MMTP, HIV incidence may rise
initially. IDUs were required to take a mandatory HIV
screening test when they joined the MMTP for the first
time. Hence, if many IDUs were infected with HIV before
taking part in the MMTP, the incidence of HIV may increase
rapidly. However, after the MMTP had been implemented
for a long time, HIV incidence may not expand as a result of
some protective factors including HIV education, HIV
counseling, and the distribution of condoms and dilution
water. Alternatively, if many IDUs participated in the MMTP
during the PHRP, we would be able to estimate the effect of
the MMTP on HIV incidence precisely. Second, despite
extensive multivariate adjustment, the association
between the PHRP and HIV incidence may be influenced by
confounders that were not measured by the study instru-
ment. These confounders include: (1) IDUs who had sterile
injection equipment but did not use it e they might
therefore share dilution water or syringes or engage in
unsafe sexual behavior, which may lead to overestimation
of the effect of the NSP on HIV incidence; (2) at the start ofthe PHRP, IDUs might not have received information
regarding the MMTP, and consequently few IDUs partici-
pated in the MMTP, which resulted in underestimation of
the effect of the MMTP on HIV incidence. In addition,
despite the fact that we were not able to perform
randomized grouping due to ethical reasons, voluntary
participation in one quarter of the total population in these
four PHRP areas with comparable initial HIV situations
(Table 2) has made comparison between the PHRP and
nonPHRP areas reasonably possible.
Despite these limitations, our study provides the first
control/experimental-based results regarding the effects
of harm reduction measures on HIV control among IDUs. Our
data indicated that whereas the PHRP measures were
associated with a reduction in the incidence of HIV, HIV
education and HIV testing were essential for effective HIV
control upon implementing these measures.
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